OKYO PHARMA LTD SP.ADR/65 (OK10) — Net Asset Quality Index
OKYO PHARMA LTD SP.ADR/65 (OK10) has a Net Asset Quality Index of -73.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €4.64 Million minus total liabilities of €8.06 Million yields net assets of €-3.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. See working capital to net assets of OKYO PHARMA LTD SP.ADR/65 to evaluate short-term liquidity relative to the company's equity base.
Quality Index
Net Assets
Total Assets
Total Liabilities
OKYO PHARMA LTD SP.ADR/65 Net Asset Quality Index Over Time (2022–2025)
This chart shows how OKYO PHARMA LTD SP.ADR/65's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at -73.5%, representing net assets of €-3.42 Million against total assets of €4.64 Million EUR. Explore OK10 cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for OKYO PHARMA LTD SP.ADR/65 (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for OKYO PHARMA LTD SP.ADR/65 from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is OKYO PHARMA LTD SP.ADR/65 worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -150.9% | €-5.55 Million | €3.68 Million | €9.23 Million | ▲ +230.6 pp |
| 2024 | -381.5% | €-5.88 Million | €1.54 Million | €7.42 Million | ▼ -342.0 pp |
| 2023 | -39.5% | €-2.05 Million | €5.20 Million | €7.26 Million | ▼ -108.0 pp |
| 2022 | 68.5% | €2.95 Million | €4.30 Million | €1.35 Million | — |